Exforge film-coated tablets

Product Information *

  • Company:

    Novartis Ireland Limited
  • Status:

    No Recent Update
  • Active Ingredients :

    *Additional information is available upon request

  • Legal Category:

    Product subject to medical prescription which may be renewed (B)

When a pharmaceutical company changes any document, a new version is published on medicines.ie. For each version, we show the dates it was published on medicines.ie and the reasons for change.

Updated on 05 May 2021

File name

Exforge_REG PIL_PF21-0073_IPHA_1620231915.pdf

Reasons for updating

  • Change to section 6 - manufacturer

Updated on 22 November 2019

File name

Exforge FCT_REG PIL_PF 19-0168_IPHA_1574437043.pdf

Reasons for updating

  • Change to section 4 - how to report a side effect
  • Change to section 6 - manufacturer
  • Change to section 6 - date of revision

Updated on 25 April 2019

File name

Exforge FCT 1136812_B18_IE_p1_LFT_X-4_IPHA_1556188964.pdf

Reasons for updating

  • Change to section 6 - marketing authorisation holder
  • Change to section 6 - date of revision

Updated on 28 March 2019

File name

REG_SmPC_Exforge Family_PF 18-0138 MAH Transfer_IPHA_1553790624.pdf

Reasons for updating

  • File format updated to PDF

Legal category:Product subject to medical prescription which may be renewed (B)

Updated on 10 July 2018

File name

Exforge family_REG_PIL_1136812_A18_IE_p1_LFT_X-4_.pdf

Reasons for updating

  • Change to section 2 - pregnancy, breast feeding and fertility
  • Change to section 4 - possible side effects
  • Change to section 6 - date of revision

Updated on 04 July 2018

File name

REG_SmPC_Exforge Family_PF 18-0138 MAH Transfer_clean.docx

Reasons for updating

  • Change to section 7 - Marketing authorisation holder

Legal category:Product subject to medical prescription which may be renewed (B)

Updated on 27 June 2018

File name

Exforge REG SmPC PF 18-0163_CLEAN.docx

Reasons for updating

  • Change to section 4.5 - Interaction with other medicinal products and other forms of interaction
  • Change to section 4.6 - Pregnancy and lactation
  • Change to section 4.8 - Undesirable effects
  • Change to section 10 - Date of revision of the text

Legal category:Product subject to medical prescription which may be renewed (B)

Updated on 16 May 2017

File name

PIL_17161_244.pdf

Reasons for updating

  • New PIL for new product

Updated on 04 April 2017

Reasons for updating

  • New SPC for new product

Legal category:Product subject to medical prescription which may be renewed (B)